Abstract
Background
Health-care-associated infection (HAI) is effect on patients for the time of staying in the hospital. Opportunistic pathogens including Pseudomonas aeruginosa are the most dangerous biological agents in nosocomial infections. This study aimed to assess the prevalence of 3 classes of integrons carrying to carbapenem resistance in P. aeruginosa strains collected from Nemazee hospital.
Methods
This cross-sectional study was conducted on clinical P. aeruginosa isolates were collected from Nemazee hospital. The identification of the isolates was performed by routine biochemical tests. Antimicrobial sensitivity testing was determined using the disk diffusion method against imipenem and meropenem. The int1, int2 and int3 genes were detected using the polymerase chain reaction (PCR).
Results
Seventy-five clinical isolates of P. aeruginosa were recovered from various clinical infections. A carbapenem-resistant phenotype was detected in 42.7% (imipenem) and 29.3% (meropenem) of isolates. As the PCR results, 48 (64%) and 15 (20%) isolates were identified as being positive for class 1 and class 2 integrons, respectively. Class 3 integrons were not found among the studied isolates.
Conclusions
Our data demonstrate the importance of class 1 and 2 integrons in carbapenem resistant P. aeruginosa strains. Therefore, integrons play an important role in acquisition and dissemination of carbapenem resistance genes among these pathogens, so, management of infection control policies and the appropriate use of antibiotics is essential for control the spreading of antibiotics resistance genes.
Keywords: Nosocomial infection, Carbapenem-resistant Pseudomonas aeruginosa, Integron
Introduction
Healthcare associated infections (HAI), or nosocomial infections are known as infectious diseases that affect patients for the time of staying in the hospital and their manifestation apparent after 48–72 hours of hospitalization (1). Significantly, nosocomial infection is related to community health and is a risk factor for the spread of infections and directly related to the economy (2). In general, surgical procedures and invasive medical devices cause this type of infection(3). Opportunistic pathogens are the most dangerous biological agents in nosocomial infections (4). A range of multidrug-resistant organisms, including Pseudomonas aeruginosa, Acinetobacter baumannii, and extended-spectrum β-lactamase (ESBL) and carbapenemase-producing Enterobacteriaceae are the cause of nosocomial infections (5). Among them, P. aeruginosa is the major cause of nosocomial infections (6).
P. aeruginosa is a non-fermentative, aerobic, and rod-shaped bacterium that has minimal nutrition requirements (7). This organism is capable of causing severe infections such as sepsis, pneumonia, urinary tract infection, bacteremia and, soft-tissue infection (8). P. aeruginosa can cause infections in immunocompromised patients, including burn wounds, and cystic fibrosis (9). Infections caused by this bacteria are frequently problematic and life-threatening, therefore mainly correlated with high mortality and morbidity rates (10). The antimicrobial resistance in P. aeruginosa is one of the major public health concerns in the world. Imipenem and meropenem as carbapenems are the most effective antibiotics for the treatment of infections caused by (multi-drug resistant) MDR strains of P. aeruginosa, but intensive clinical use of carbapenems has caused an increase in carbapenem resistance (11). Integrons are potentially mobile genetic elements that capture and incorporate gene cassettes by sites specific recombination and convert them to functional genes. They play a central role in the dissemination of resistance genes among gram-negative bacteria, especially in Pseudomonas (12,13). This element contains three necessary components including the intI encoding an integrase gene, attI encoding the attachment site and the promoter region (PC) (14). Today, in Gram-negative bacteria, three types of integrons have been recognized with different int genes (IntI1, IntI2, and IntI3), that are associated with resistance gene cassettes (14). However, class 1 integron is the most widespread among clinical isolates of P. aeruginosa, which confer resistance to aminoglycosides, beta-lactams, chloramphenicol, carbapenems, macrolides agents (15).
Evidence recommends that integrons are coding and responsible for the dissemination of carbapenem resistance among P. aeruginosa isolates (16). The results of this study can be relatively important for choosing an effective antibiotic to manage infection of P. aeruginosa in the hospital environment. This study aimed to assess the prevalence of 3 classes of integrons in carbapenem-resistant P. aeruginosa strains collected from Nemazee hospital.
Materials and Methods
Bacterial isolates and identification: Seventy-five non-duplicated clinical P. aeruginosa isolates were recovered from various clinical infections to Nemazee hospital from August 2015 to February 2016. These strains were isolated from various clinical infections including urinary tract infection (UTI), respiratory tract infection (RTI), eye infection (EI), bloodstream infection (BSI), skin and soft tissue infection (SSTI), and abdominal infection (AI). The identification of the intended isolates was performed by using routine biochemical tests as previously described (17).
Antibiotic susceptibility testing: Antimicrobial sensitivity testing was carried out using the disk diffusion method on Muller-Hinton agar against imipenem and meropenem as previously recommended in the Clinical and Laboratory Standards Institute (CLSI) (18). All antibiotic disks were provided from Mast Co., UK. The plates were incubated for 24 h at 37°C. Then, the results were interpreted as susceptible, intermediately susceptible and resistant. Intermediate-susceptible isolates were considered as resistant. P. aeruginosa ATCC27853 was included as the control strain in each run of drug susceptibility testing.
Detection of int genes by PCR: Deoxyribonucleic acid (DNA) extraction for the detection of integron genes was performed by the boiling method as previously described (19). The extracted DNA was stored at -20°C for its use as a DNA template in PCR reactions. The detection of int1, int2 and int3 genes were carried out using the polymerase chain reaction (PCR) by the set of primers are listed in Table 1. PCR mix was performed in a final volume of 25 µl containing 2 µL template DNA, 0.2 mM of each deoxynucleoside triphosphate, 10 pmol of each primer, 10 mM Tris-HCl, 1.5 mM MgCl2, 50 mMKCl, and 1.5 U of Taq DNA polymerase. The amplification was achieved in a T100™ thermal cycler (Bio-Radd, Hercules, CA, USA), with the following program: initial denaturation at 94°C for 5 min, 30 cycles of denaturation at 94°C for 60s, primer annealing at 57°C for 60s, extension at 72°C for 2 min and a final extension at 72°C for 10 min. The PCR products were separated using 1.5% agarose gel electrophoresis containing safe DNA stain and visualized in the UV illuminator.
Table 1.
Primer | Sequence (5′ to 3′) | Amplicon Size (bp) | References |
int1-F | GGTCAAGGATCTGGATTTCG | 483 | 20 |
int1-R | ACATGCGTGTAAATCATCGTC | ||
int2-F | CACGGATATGCGACAAAAAGGT | 789 | 20 |
int2-R | GTAGCAAACGAGTGACGAAATG | ||
int3-F | AGTGGGTGGCGAATGAGTG | 600 | 20 |
int3-R | TGTTCTTGTATCGGCAGGTG |
Data analysis: Analysis was performed by using SPSSTM software, version 21.0 (IBM Corp., USA). The results are presented as descriptive statistics in terms of relative frequency. Values were expressed as the mean ± standard deviation (continuous variables) or percentages of the group (categorical variables).
Results
In this cross-sectional study, 75 clinical isolates of P. aeruginosa were examined. Forty and thirty-five of isolates were from male and female patients, respectively. The range of age among patients was from 10 days to 77 years-old. All isolates of P. aeruginosa were recovered from different clinical infections including 26 (34.6%) isolates from urinary tract infection, 25 (33.3%) isolates from respiratory tract infection, nine (12%) isolates from bloodstream infection, five (6%) isolates from each eye, skin and soft tissue and abdominal infections. Intensive care unit with 39 isolates (52%), and transplant unit with 5 isolates (6%), were comprised of the highest and lowest rates of P. aeruginosa isolation respectively.
A carbapenem-resistant phenotype was detected in 42.7% (imipenem) and 29.3% (meropenem) of P. aeruginosa isolates. As the PCR results, 48 (64%) and 15 (20%) isolates were identified as being positive for class 1 and class 2 integrons, respectively. Class 3 integrons were not found among the studied isolates. Frequency of class 1 and class 2 integrons were 29 (60%) and 8 (53.3%) in imipenem resistance isolates, respectively. Whereas in meropenem resistance isolates these frequencies were 19 (86%) and 7 (31.8%), respectively. 7 (21.8%) imipenem resistant isolates and 6 (27.2%) meropenem resistant isolates harbored both integrons (class 1 and 2).
The distribution of class 1 integron among the isolates according to originated clinical infections was highest for urine (46.2%), and respiratory tract (30.8%) infections (Table 2). As shown in Table 2, among the clinical infections, the frequency of class 2 integron is high (69.2%) in respiratory tract infections. The majority of isolates harbored class 1 and 2 integrons were from the ICU ward (48.7%, 46.1%) followed by Internal (33.3%, 38.5%), Surgery (12.8%, 7.7%) and Transplant (5.2%, 7.7%) wards.
Table 2.
Infection | Class I integron No. (%) |
Class II integron No. (%) |
RTI | 12 (30.8) | 9 (69.2) |
EI | 2 (5.1) | 1 (7.7) |
BSI | 4 (10.2) | 0 |
UTI | 18 (46.2) | 3 (23.1) |
SSTI | 1 (2.6) | 0 |
AI | 2 (5.1) | 0 |
UTI: urinary tract infection, RTI: respiratory tract infection, EI: eye infection, BSI: bloodstream infection, SSTI: skin and soft tissue infection, AI: abdominal infection
Discussion
There are restricted therapeutic choices for the treatment of P. aeruginosa. Therefore treatment by the last line of drugs is considered for the management of infections created by these bacteria (20). A recent study have revealed that many resistance genes can be transferred by integrons (21). Integron particularly contributes to the horizontal transmission of genes involved in antibiotic resistance among clinical isolates of P. aeruginosa (22). This study aimed to investigate the presence of class 1, 2 and 3 integrons in P. aeruginosa isolated from southwest of Iran.
In the present study, the resistance rate to carbapenem in P. aeruginosa isolates was 42.6%. This rate was reported ranging 11% to 61% in Iranian studies (23–26), while other countries showed ranging from 12.9% to 38% (27–31). Several factors are involved in these differences between the regions such as the variation in the studied population, infection control policy, and testing methods. Also, it has been suggested that three factors are significantly associated with the emergence of carbapenem-resistant P. aeruginosa isolates including MDR phenotype, hospitalization in burn units and the presence of class 1 integrons (22).
Although it is clear that multiple mechanisms are related to antibiotic resistance in P. aeruginosa isolates, the role of integrons in the resistance acquisition of this bacterium are inevitable (32). The integrons screening in this study reveals that the majority of (64%) P. aeruginosa isolates carried class 1 integrons. Numerous studies on different clinical samples reported the prevalence of integrons among P. aeruginosa isolates from Iran and other parts of the world, and most of them reported a higher incidence of class 1 integron (16, 20, 33–36). Also, the prevalence rate of class 1 integrons detected in this study is higher than the previously reported rate of from Brazil (41.5%) (37), and China (45.8 %) (38). This low rate is possibly due to the difference in the geographical area and the studied population.
In line with our findings, several previous studies showed a low rate of class 2 integrons in clinical isolates of P. aeruginosa (21, 35, 36, 38–41). The absence or sporadic detection of class 2 integrons were confirmed the restricted distribution of these genetic elements among bacterial populations.
In summary, Our data demonstrate the importance of class 1 and 2 integrons in carbapenem resistant P. aeruginosa strains isolated from different parts of the hospital that suggest the high potential of this structure to be transferred among bacteria by the horizontal gene transfer apparatus. We reported a high prevalence of class 1 integrons in clinical isolates of P. aeruginosa whereas the frequency of class 2 integrons was low. This difference indicates a high risk of resistance transmission and dissemination of integron producing isolates in hospitals. Therefore, integrons play an important role in acquisition and dissemination of carbapenem resistance genes among these pathogens, so, management of infection control policies and the appropriate use of antibiotics is essential for control the spreading of antibiotics resistance genes.
The lack of investigation and characterization of resistance gene cassettes associated with class 1 and 2 integrons can be mentioned as one of the main limitations of the present study.
Acknowledgements
This study was financially supported by Shiraz University of Medical Sciences grant No. 96-15538. This paper was part of the MD thesis of Ms. Zahra Sadat Tabatabaei supervised by Dr. Mohammad Motamedifar. We thank all participants and personals at the studied hospital for their friendly cooperation.
References
- 1.Peleg AY, Hooper DC. Hospital-acquired infections due to gram-negative bacteria. NEJM. 2010;362:1804–1813. doi: 10.1056/NEJMra0904124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Samuel S, Kayode O, Musa O, et al. Nosocomial infections and the challenges of control in developing countries. African J Clin Exp Microbiol. 2010;11 [Google Scholar]
- 3.Sun B. Nosocomial infection in China: management status and solutions. Am J Infect Control. 2016;44:851–852. doi: 10.1016/j.ajic.2016.01.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Akbari R, Bafghi MF, Fazeli H. Nosocomial Infections Pathogens Isolated from Hospital Personnel, Hospital Environment and Devices. J Med Bacteriol. 2018;7:22–30. [Google Scholar]
- 5.Weinstein RA, Gaynes R, Edwards JR, et al. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis. 2005;41:848–854. doi: 10.1086/432803. [DOI] [PubMed] [Google Scholar]
- 6.Quinn JP, editor. Pseudomonas aeruginosa infections in the intensive care unit. Seminars in respiratory and critical care medicine. 2003. Copyright© 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New .... [DOI] [PubMed] [Google Scholar]
- 7.Rossolini G, Mantengoli E. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin Microbiol Infect. 2005;11:17–32. doi: 10.1111/j.1469-0691.2005.01161.x. [DOI] [PubMed] [Google Scholar]
- 8.Morrison AJ, Jr, Wenzel RP. Epidemiology of infections due to Pseudomonas aeruginosa. Rev Infect Dis. 1984;6:S627–S42. doi: 10.1093/clinids/6.supplement_3.s627. [DOI] [PubMed] [Google Scholar]
- 9.Driscoll JA, Brody SL, Kollef MH. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs. 2007;67:351–368. doi: 10.2165/00003495-200767030-00003. [DOI] [PubMed] [Google Scholar]
- 10.Pachori P, Gothalwal R, Gandhi P. Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review. GENES DIS. 2019;6:109. doi: 10.1016/j.gendis.2019.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Rojo-Bezares B, Cavalié L, Dubois D, et al. Characterization of carbapenem resistance mechanisms and integrons in Pseudomonas aeruginosa strains from blood samples in a French hospital. J Med Microbiol. 2016;65:311–319. doi: 10.1099/jmm.0.000225. [DOI] [PubMed] [Google Scholar]
- 12.Carattoli A. Importance of integrons in the diffusion of resistance. Vet Res. 2001;32:243–259. doi: 10.1051/vetres:2001122. [DOI] [PubMed] [Google Scholar]
- 13.Maguire AJ, Brown DF, Gray JJ, et al. Rapid screening technique for class 1 integrons inenterobacteriaceae and nonfermenting gramnegative bacteria and its use in molecular epidemiology. Antimicrob Agents Chemother. 2001;45:1022–1029. doi: 10.1128/AAC.45.4.1022-1029.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Leverstein-van Hall MA, M Blok HE, T Donders AR, et al. Multidrug resistance among Enterobacteriaceae is strongly associated with the presence of integrons and is independent of species or isolate origin. J Infect Dis. 2003;187:251–259. doi: 10.1086/345880. [DOI] [PubMed] [Google Scholar]
- 15.Alekshun MN, Levy SB. Molecular mechanisms of antibacterial multidrug resistance. Cell. 2007;128:1037–1050. doi: 10.1016/j.cell.2007.03.004. [DOI] [PubMed] [Google Scholar]
- 16.Hosseini SMJ, Naeini NS, Khaledi A, et al. Evaluate the relationship between class 1 integrons and drug resistance genes in clinical isolates of Pseudomonas aeruginosa. Open Microbiol J. 2016;10:188. doi: 10.2174/1874285801610010188. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Winn W AS, Janda W, Koneman E, Procop G, Schreckenberger P. Koneman's Color Atlas and Textbook of Diagnostic microbiology. 6 ed. Philadelphia: Lippincott Williams & Wilkins; 2006. [Google Scholar]
- 18.CLSI, author. Performance Standards for Antimicrobial Susceptibility Testing. 30th ed. Wayne PCaLSI. PA: Clinical and Laboratory Standards Institute; 2020. CLSI supplement M100. [Google Scholar]
- 19.Sheikh AF, Rostami S, Jolodar A, et al. Detection of metallo-beta lactamases among carbapenem-resistant Pseudomonas aeruginosa. Jundishapur J Microbiol. 2014;7 doi: 10.5812/jjm.12289. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Yousefi S, Nahaei M, Farajnia S, et al. Class 1 integron and imipenem resistance in clinical isolates of Pseudomonas aeruginosa: prevalence and antibiotic susceptibility. Iran J Microbiol. 2010;2:115. [PMC free article] [PubMed] [Google Scholar]
- 21.Mobaraki S, Aghazadeh M, Barhaghi MHS, et al. Prevalence of integrons 1, 2, 3 associated with antibiotic resistance in Pseudomonas aeruginosa isolates from Northwest of Iran. BioMedicine. 2018;8 doi: 10.1051/bmdcn/2018080102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Heidarzadeh S, Enayati Kaliji Y, Pourpaknia R, et al. A meta-analysis of the prevalence of class 1 integron and correlation with antibiotic resistance in Pseudomonas aeruginosa recovered from Iranian burn patients. J Burn Care Res. 2019;40:972–978. doi: 10.1093/jbcr/irz135. [DOI] [PubMed] [Google Scholar]
- 23.Khosravi AD, Mihani F. Detection of metallo-β-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients in Ahwaz, Iran. Diagn Microbiol Infect Dis. 2008;60:125–128. doi: 10.1016/j.diagmicrobio.2007.08.003. [DOI] [PubMed] [Google Scholar]
- 24.Nikokar I, Tishayar A, Flakiyan Z, et al. Antibiotic resistance and frequency of class 1 integrons among Pseudomonas aeruginosa, isolated from burn patients in Guilan, Iran. Iran J Microbiol. 2013;5:36. [PMC free article] [PubMed] [Google Scholar]
- 25.Shahcheraghi F, Nikbin VS, Feizabadi MM. Identification and genetic characterization of metallo-beta-lactamase-producing strains of Pseudomonas aeruginosa in Tehran, Iran. New Microbiol. 2010;33:243–248. [PubMed] [Google Scholar]
- 26.Yousefi S, Farajnia S, Nahaei MR, et al. Detection of metallo-β-lactamase-encoding genes among clinical isolates of Pseudomonas aeruginosa in northwest of Iran. Diagn Microbiol Infect Dis. 2010;68:322–325. doi: 10.1016/j.diagmicrobio.2010.06.018. [DOI] [PubMed] [Google Scholar]
- 27.Castanheira M, Bell JM, Turnidge JD, et al. Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-β-lactamase clones (VIM-2,-5,-6, and-11 and the newly characterized VIM-18) Antimicrob Agents Chemother. 2009;53:1225–1227. doi: 10.1128/AAC.01011-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Chin BS, Han SH, Choi SH, et al. The characteristics of metallo-β-lactamaseproducing gram-negative bacilli isolated from sputum and urine: a single center experience in Korea. Yonsei Med J. 2011;52:351–357. doi: 10.3349/ymj.2011.52.2.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Wang J, Zhou J-y, Qu T-t, et al. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals. Int J Antimicrob Agents. 2010;35:486–491. doi: 10.1016/j.ijantimicag.2009.12.014. [DOI] [PubMed] [Google Scholar]
- 30.Kouda S, Ohara M, Onodera M, et al. Increased prevalence and clonal dissemination of multidrug-resistant Pseudomonas aeruginosa with the bla IMP-1 gene cassette in Hiroshima. J Antimicrob Chemother. 2009;64:46–51. doi: 10.1093/jac/dkp142. [DOI] [PubMed] [Google Scholar]
- 31.Franco MRG, Caiaffa-Filho HH, Burattini MN, et al. Metallo-beta-lactamases among imipenem-resistant Pseudomonas aeruginosa in a Brazilian university hospital. Clinics. 2010;65:825–829. doi: 10.1590/S1807-59322010000900002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Sultan I, Rahman S, Jan AT, et al. Antibiotics, resistome and resistance mechanisms: a bacterial perspective. Front Microbiol. 2018;9:2066. doi: 10.3389/fmicb.2018.02066. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Goli HR, Nahaei MR, Rezaee MA, et al. Prevalence and molecular characterization of Class 1 integrons among clinical isolates of Pseudomonas aeruginosa in Northwest of Iran. Mol Gen Microbiol Virol. 2017;32:109–115. [Google Scholar]
- 34.Odumosu BT, Adeniyi BA, Chandra R. Analysis of integrons and associated gene cassettes in clinical isolates of multidrug resistant Pseudomonas aeruginosafrom Southwest Nigeria. Ann Clin Microbiol Antimicrob. 2013;12:29. doi: 10.1186/1476-0711-12-29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Khosravi AD, Motahar M, Montazeri EA. The frequency of class1 and 2 integrons in Pseudomonas aeruginosa strains isolated from burn patients in a burn center of Ahvaz, Iran. PloS one. 2017;12 doi: 10.1371/journal.pone.0183061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Chairat S, Ben Yahia H, Rojo-Bezares B, et al. High prevalence of imipenem-resistant and metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Burns Hospital in Tunisia: detection of a novel class 1 integron. J Chemother. 2019;31:120–126. doi: 10.1080/1120009X.2019.1582168. [DOI] [PubMed] [Google Scholar]
- 37.Fonseca ÉL, Vieira VV, Cipriano R, et al. Class 1 integrons in Pseudomonas aeruginosa isolates from clinical settings in Amazon region, Brazil. FEMS Microbiol. Immunol. 2005;44:303–309. doi: 10.1016/j.femsim.2005.01.004. [DOI] [PubMed] [Google Scholar]
- 38.Xu Z, Li L, Shirtliff ME, et al. Occurrence and characteristics of class 1 and 2 integrons in Pseudomonas aeruginosa isolates from patients in southern China. J Clin Microbiol. 2009;47:230–234. doi: 10.1128/JCM.02027-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Khorramrooz SS, Gharibpour F, Parhizgari N, et al. Prevalence of Class 1 integron and antibiotic resistance among Pseudomonas aeruginosa isolated from patients admitted to the burn unit at Taleghani hospital in Ahvaz. J Arak Uni Med Sci. 2015;18:9–18. [Google Scholar]
- 40.Khosravi Y, Tay ST, Vadivelu J. Analysis of integrons and associated gene cassettes of metallo-β-lactamase-positive Pseudomonas aeruginosa in Malaysia. J Med Microbiol. 2011;60:988–994. doi: 10.1099/jmm.0.029868-0. [DOI] [PubMed] [Google Scholar]
- 41.Haghi F, Keramati N, Hemmati F, et al. Distribution of integrons and gene cassettes among metallo-β-lactamase producing Pseudomonas aeruginosa clinical isolates. Epidemiol Infect and mocrobiol. 2017;3:36–40. [Google Scholar]